Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 174Endometrial Neoplasms 110Uterine Cervical Neoplasms 95Breast Neoplasms 54Colorectal Neoplasms 49Fallopian Tube Neoplasms 44Carcinoma, Non-Small-Cell Lung 42Neoplasms 34Pancreatic Neoplasms 31Neoplasm Metastasis 27Stomach Neoplasms 26Prostatic Neoplasms 25Melanoma 24Squamous Cell Carcinoma of Head and Neck 22Lung Neoplasms 22Esophageal Neoplasms 22Triple Negative Breast Neoplasms 20Carcinoma, Renal Cell 19Carcinoma, Ovarian Epithelial 19Urinary Bladder Neoplasms 18Sarcoma 16Carcinoma, Transitional Cell 16Head and Neck Neoplasms 15Colonic Neoplasms 15Carcinoma, Hepatocellular 15Cholangiocarcinoma 14Small Cell Lung Carcinoma 13Vulvar Neoplasms 12Uterine Neoplasms 12Rectal Neoplasms 12

Interventions

Positron-Emission Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Toxemia × Gynecologic × 30 days × Clear all
NCT05632601 2026-05-08

HER-CROWN

Ottawa Heart Institute Research Corporation

Phase NA Active not recruiting
176 enrolled
BreastGynecologic

Breast Neoplasms, Cardiovascular Diseases, Polycystic Ovary Syndrome, Toxemia, Diabetes, Gestational, Primary Ovarian Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡